Olema Oncology
The Medical Director, Clinical Development serves as an Oncology Physician for palazestrant, playing a pivotal role in advancing Olema’s late and early-stage clinical pipeline in breast cancer. This position involves contributing to registration-enabling studies by shaping study design, evaluating clinical data, and engaging with regulatory authorities, investigators, and key opinion leaders. The role ensures scientific rigor, data integrity, and patient-centric decision-making while supporting biomarker development and external scientific communications.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2007
Olema Oncology is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel targeted therapies for metastatic breast cancer and beyond. The company leverages its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to advance its pipeline, including Phase 3 breast cancer trials and a KAT6 inhibitor program being evaluated in solid tumors and prostate cancer. Founded in 2006 and headquartered in San Francisco, California, Olema trades on Nasdaq under the ticker OLMA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Olema Oncology.
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Medical Director/Senior Medical Director, Clinical Development (Prostate)
ORIC Pharmaceuticals Inc
Medical Director, Clinical Science – Thoracic Oncology
BioLife Plasma Services
Senior Medical Director, Oncology Clinical Development
Zailab
Global Development Team Lead, Clinical Development – Lung Cancer
Revolution Medicines
Director, Medical Affairs - Oncology and Hematologic Malignancies
Labcorp
Physician - Breast Oncologist
The University of Kansas Health System